Hofseth BioCare ASA
HOFBFOTCHealthcare● Active
$0.17
+$0.00(+0.00%)
Market Cap$65819620
P/E Ratio—
52W High$0.176
52W Low$0.155
Hofseth BioCare ASA (HOFBF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HOFBF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.25B | $0.26B | $0.19B | $0.12B | $0.09B |
| Cost of Revenue | $0.29B | $0.17B | $0.15B | $0.09B | $0.06B |
| Gross Profit | ($0.03B) | $0.09B | $0.04B | $0.03B | $0.02B |
| Gross Margin %(computed) | -12.76% | 34.13% | 22.67% | 23.67% | 26.36% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.01B | $0.01B | $0.01B |
| G&A Expenses | $0.00B | $0.03B | $0.02B | $0.02B | $0.03B |
| Total Operating Expenses | $0.08B | $0.20B | $0.15B | $0.16B | $0.14B |
| Operating Income | ($0.11B) | ($0.11B) | ($0.10B) | ($0.13B) | ($0.12B) |
| Operating Margin %(computed) | -44.29% | -43.98% | -52.61% | -106.78% | -135.32% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.02B | $0.02B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | ($0.13B) | ($0.12B) | ($0.11B) | ($0.14B) | ($0.13B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.13B) | ($0.12B) | ($0.11B) | ($0.14B) | ($0.13B) |
| Net Margin %(computed) | -53.01% | -47.94% | -54.74% | -114.06% | -144.34% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.33 | $-0.30 | $-0.27 | $-0.37 | $-0.35 |
| Wtd Avg Shares | 0.41B | 0.41B | 0.40B | 0.37B | 0.36B |
| EBITDA | ($0.07B) | ($0.07B) | ($0.06B) | ($0.10B) | ($0.09B) |
| EBITDA Margin %(computed) | -28.80% | -26.39% | -32.19% | -80.54% | -100.12% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · NOK · B
Explore more Hofseth BioCare ASA data
About Hofseth BioCare ASA (HOFBF) Income Statement
Hofseth BioCare ASA (HOFBF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, HOFBF reported revenue of $0.25B, gross profit of ($0.03B) (gross margin -12.76%), and net income of ($0.13B) — a net profit margin of -53.01%.
Frequently asked questions
HOFBF · 4 questionsHofseth BioCare ASA (HOFBF) reported revenue of $0.25B for 2025, down 1.2% year-over-year.
HOFBF revenueHOFBF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09